Immediate Impact
5 from Science/Nature 65 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Antisense oligonucleotide therapeutic approach for Timothy syndrome
2024 StandoutNature
Works of Matthew Jaffa being referenced
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Matthew Jaffa | 404 | 19 | 37 | 225 | 111 | 23 | 536 | |
| Thomas Julian | 224 | 81 | 57 | 95 | 25 | 598 | ||
| Murat Kalaycı | 130 | 16 | 50 | 68 | 68 | 38 | 602 | |
| Sarita Khanna | 143 | 5 | 37 | 87 | 50 | 39 | 630 | |
| C. A. Maurage | 171 | 6 | 77 | 61 | 172 | 22 | 644 | |
| Jesús Pradas | 305 | 4 | 14 | 110 | 51 | 17 | 461 | |
| Petr Ridzoň | 212 | 7 | 38 | 78 | 26 | 483 | ||
| Hans‐Jürgen Gdynia | 280 | 24 | 39 | 110 | 147 | 26 | 597 | |
| A. M. G. Campbell | 208 | 1 | 37 | 34 | 85 | 34 | 595 | |
| Peter Kühnlein | 329 | 5 | 19 | 195 | 64 | 13 | 514 | |
| John B. Hiebert | 161 | 16 | 110 | 19 | 211 | 22 | 468 |
All Works
Login with ORCID to disown or claim papers
Loading papers...